This article was originally published in The Tan Sheet
Male enhancement supplement manufacturer Berkeley Premium Nutraceuticals made unsubstantiated claims about Enzyte's ability to increase penis size "despite [Berkeley's] knowledge that there was no legitimate scientific basis supporting the claims," alleges a class-action lawsuit filed in Montgomery, Ohio County Court, March 17. The suit is filed on behalf of a consumer who paid $400 for an eight-month supply of the product and received only a portion of the refund he was promised after the product did not work as promised. Firm recently was asked by the Council of Better Business Bureau's National Advertising Division to discontinue performance claims because anecdotal evidence supporting the claims was found to be insufficient (1"The Tan Sheet" Aug. 25, 2003, p. 16)...
You may also be interested in...
In a decision that will make executives think twice before taking part in making false claims and other deceptive behavior, an Ohio court sentenced 11 former employees of Berkeley Premium Nutraceuticals to prison for conspiracy, fraud and money laundering convictions related to marketing its Enzyte "natural male enhancement" product
Lifekey Healthcare should discontinue performance and efficacy claims for its Enzyte Male Enhancement Program, due in part to insufficient clinical evidence of the product's performance and efficacy, the National Advertising Division says
Policy experts predicted how the incoming Biden administration will handle health care issues at a recent Alliance for Health Policy webinar. Rachel Nuzum, VP of state and federal policy at The Commonwealth Fund, said telehealth could be a priority.